The enzymatic subunit of Shiga toxin (StxA1) is a member of the ribosome-inactivating protein (RIP) family, which includes the ricin A chain as well as other examples of plant toxins. StxA1 catalytically depurinates a well-conserved GAGA tetra-loop of 28S rRNA which lies in the acceptor site of eukaryotic ribosomes. The specific activities of native StxA1, as well as mutated forms of the enzyme with substitutions in catalytic site residues, were measured by an in vitro translation assay. Electroporation was developed as an alternative method for the delivery of purified A1 polypeptides into Vero cells. Site-directed mutagenesis coupled with N-bromosuccinimide modification indicated that the sole tryptophan residue of StxA1 is required for binding it to the 28S rRNA backbone. Northern analysis established that the catalytic site substitutions reduced enzymatic activity by specifically interfering with the capacity of StxA1 to depurinate 28S rRNA. Ribosomes were protected from StxA1 by molar excesses of tRNA and free adenine, indicating that RIPs have the capacity to enter the acceptor site groove prior to binding and depurinating the GAGA tetra-loop.
Shiga toxin (STX) is a multimeric molecule consisting of a single 32-kDa enzymatic A subunit (StxA) noncovalently associated with a ring of five 7.7-kDa B subunits (StxB) (17) . The StxB subunits mediate the binding of toxin to its receptor on eukaryotic membranes, and the entire STX molecule enters cells via endocytosis from coated pits (28) . StxA is processed in the trans-Golgi network by the cellular protease furin (11) to release StxA1, which possesses the enzymatic activity, and StxA2, which acts as a bridge between StxA1 and the B pentamer. StxA1 is an N-glycosidase which catalytically removes a specific adenine from a well-conserved tetra-loop of 28S rRNA and thus inhibits protein synthesis by preventing the binding of aminoacyl tRNAs to the ribosome and halting protein elongation (7) . StxA1 is a member of the ribosome-inactivating protein (RIP) family of enzymes, which are a large group of protein synthesis inhibitors primarily found in the leaves, seeds, and roots of dicotyledonous plants (5, 7, 30) . The only RIPs identified so far which are not produced by plants are the members of the STX family of toxins.
The catalytic sites of StxA1 have been identified by sequence comparison of RIP family members and site-specific mutagenesis. Amino acid substitutions in three regions of StxA1 which are highly conserved among the RIPs identified tyrosine 77, glutamic acid 167, arginine 170, and tryptophan 203 as important for catalytic activity (2, 16, 33) . Corresponding mutations in another RIP, the A chain of the plant lectin ricin (RTA), corroborated the findings with StxA1 (24, 29) .
The X-ray crystal structures of StxA1 and RTA have been solved at 2.5 Å (10, 20) . Comparison of these structures revealed an active site cleft which contains all of the catalytic site residues previously identified by site-specific mutagenesis. Xray crystallographic analysis of StxA1 and RTA also revealed the resemblance of these enzymes to a tRNA molecule. This observation suggests that the RIPs have the capacity to enter the ribosome acceptor site where the target adenine is located.
The purpose of this study was to quantify the effects of catalytic site substitutions W203A, R205A, and E167D in the STX A1 subunit. The capacity of tRNA to competitively block the RIP-mediated depurination of eukaryotic ribosomes was also investigated.
MATERIALS AND METHODS
Bacterial strains and recombinant plasmids. The following strains of Escherichia coli were used in this study: HB101 (supE44 hsdS20 r Table 1 . Oligonucleotides. Oligonucleotides used in this study (Table 2) were synthesized by the Wayne State University Biochemistry Department Core Facility using an Applied Biosystems Model 380A DNA synthesizer with phosphoramidite chemistry.
Preparation of crude toxin extracts. Crude toxin extracts were prepared by sonication of bacterial cultures. Thirty-milliliter overnight cultures were concentrated 10-fold in culture supernatant by centrifugation and lysed by sonication with a Model 300 Sonic Dismembrator (Fisher). Cells were sonicated at 50% power for a total of 3 min in 15-s bursts. Lysates were clarified by centrifugation and filter sterilized. Total protein content was measured, and samples were normalized to contain equivalent concentrations.
Column purification of native and mutated StxA1. The recombinant pET22b(ϩ) vectors carrying native and mutated stxA1 genes were transformed into the E. coli host BL21(DE3)pLysS by the calcium chloride-heat shock method (27) . BL21(DE3)pLysS permits the IPTG (isopropyl-␤-D-thiogalactopyranoside) induction of genes carried by the pET vectors (13) . BL21(DE3)pLysS growth and protein induction were conducted according to the manufacturer's (Novagen, Madison, Wis.) recommendations.
Nickel (Ni 2ϩ -nitrilotriacetic acid) affinity columns (Qiagen, Chatsworth, Calif.) were used to purify wild-type and mutated StxA1. The pET22 vector produces a fusion protein with six His residues at the C terminus which binds with high affinity to the Ni 2ϩ resin. Weakly bound proteins were removed by washing with 15 ml of a buffer containing a low concentration of imidazole (30 mM imidazole, 0.5 M sodium chloride, 20 mM Tris [pH 7.9]), and the desired proteins were eluted with 15 ml of 1 M imidazole in the same buffer. One-milliliter fractions were collected, and 20-l samples were analyzed by sodium dodecyl sulfate (SDS)-12% polyacrylamide gel electrophoresis. Fractions containing a unique 29-kDa protein were dialyzed overnight against 4 liters of phosphatebuffered saline (0.13 M sodium chloride, 5.5 mM sodium phosphate dibasic, 3.2 mM potassium phosphate monobasic [pH 7.4]) at 4ЊC. Protein content was determined with the Bio-Rad Protein Assay Kit with a bovine serum albumin standard, and samples were stored in aliquots at Ϫ70ЊC. The STX A1 polypeptide purified by this system contained six His residues at the C terminus.
NBS oxidation.
The active site residue tryptophan 203 was chemically modified with N-bromosuccinimide (NBS) according to the methods of Lundblad (22) and Guillot et al. (14) to assess its contribution to the enzymatic activity of StxA1. NBS specifically oxidizes the indole rings of tryptophan residues to form oxindole rings. NBS-mediated oxidation of the tryptophan residue in StxA1 was monitored as a decrease in UV absorbance at 280 nm (22) .
One hundred microliters of a 1 M solution of StxA1 in 0.1 M sodium acetate (pH 4.5) was mixed with a twofold molar excess of freshly prepared NBS (15 l of a 14.3-mg/ml solution in sodium acetate). Mixtures were incubated in the dark for 10 min at room temperature, and the oxidation reaction was stopped by the addition of dithiothreitol (DTT) at a final concentration of 3 mM (10 l of a 5.1-mg/ml solution in sodium acetate). The oxidation of Trp residues was confirmed by monitoring the decrease in UV absorbance at 280 nm. A 1 M solution of unmodified StxA1 had an absorbance of 0.641 at 280 nm, whereas modification with a twofold molar excess of NBS for 10 min at room temperature reduced this absorbance to 0.224. Samples were dialyzed overnight against 3 liters of 1ϫ phosphate-buffered saline at 4ЊC and used in the rabbit reticulocyte lysate in vitro translation assay.
Under these reaction conditions, NBS has been shown to selectively oxidize tryptophan residues without significantly modifying other amino acids, inducing peptide cleavage, or altering cyanogen bromide peptide patterns (14) .
Construction of recombinant plasmids. The PCR (25) was used to introduce mutations and/or restriction sites in stxA1 for the construction of the following recombinant plasmids.
(i) pEW3-W203A/G204A/R205A. The contributions of two catalytic site residues, tryptophan 203 and arginine 205, to the activity of StxA1 were investigated by substitution with alanine residues. The paired PCR primers EcoFOR/ NotREV and NotFOR/BamREV (Table 2) were used to amplify an 810-bp stxAЈ fragment and a 540-bp stxAЈB fragment from pEW3 (Table 1) , respectively. The NotREV and NotFOR primers simultaneously incorporated the NotI restriction site and the codon changes for the tryptophan 203-to-alanine, glycine 204-toalanine, and arginine 205-to-alanine substitutions designated W203A/G204A/ R205A. The two gel-purified PCR products were restricted with the appropriate enzymes and ligated to EcoRI/BamHI-restricted pBR329 to construct the entire stxAB operon with the codon changes for W203A/G204A/R205A. The ligation mixture was transformed into E. coli HB101 by the calcium chloride-heat shock method (27) , and transformants were screened for the appropriate antibiotic susceptibilities and restriction patterns. The resulting plasmid was designated pEW3-W203A/G204A/R205A.
(ii) pLS10, pLS10-E167D, and pLS10-W203A/G204A/R205A. The genes encoding wild-type and mutated StxA1 were introduced into the inducible protein purification vector pET22b(ϩ) (Novagen) to obtain purified preparations of the enzyme for quantitative analyses. The PCR primers BamSTX and XhoSTX were used to amplify 800-bp stxA1 fragments from pEW3, pEW3-W203A/G204A/ R205A, and pEW3 carrying a glutamic acid 167-to-aspartic acid substitution in the STX A1 subunit (designated pEW3-E167D). The 261-amino-acid STX A1 polypeptide encoded by the amplification product of XhoSTX and BamSTX has been previously shown to retain 90% of wild-type enzymatic activity (15) . Gelpurified PCR products were restricted and ligated to BamHI-and XhoI-restricted pET22b(ϩ) and transformed into E. coli HB101. The resulting plasmids were designated pLS10 (encoding wild-type StxA1), pLS10-E167D (encoding StxA1-E167D), and pLS10-W203A/G204A/R205A (encoding StxA1-W203A/ G204A/R205A).
Rabbit reticulocyte lysate in vitro translation assay. The capacity of native and mutated StxA1 to inhibit eukaryotic protein synthesis was assessed by a rabbit reticulocyte lysate in vitro translation system programmed with luciferase mRNA (Promega, Madison, Wis.). Thirty-one microliters of the reticulocyte lysate was incubated with 5 l of StxA1 at various concentrations for 20 min at 37ЊC. Components of the translation reaction were added (1 l each of 1 mM amino acid mixture minus Leu and amino acid mixture minus Met, 1 l of luciferase mRNA [0.3 g/l], and 12 l of H 2 O), and the samples were incubated for 2 h at 30ЊC. Ribosome activity was measured by mixing 1 l of the translation mixture with 1 l of luciferin (4.7 mM) in 25 l of luciferase assay buffer (20 mM Tris [pH 7.8], 1.07 mM magnesium carbonate, 2.67 mM magnesium sulfate, 0.1 mM EDTA, and 33.3 mM DTT, with freshly added 0.27 mM coenzyme A and 0.53 mM ATP). Five microliters of this reaction mixture was diluted with 25 l of luciferase assay buffer, and visible light was detected by a luminometer (1450 Microbeta Plus; Wallac, Gaithersburg, Md.). Various concentrations of puromycin and RTA were used as controls in these assays.
The rabbit reticulocyte system was used to assess the capacity of the competitive inhibitors tRNA and adenine to protect eukaryotic ribosomes from depurination by StxA1. The competition studies were conducted by incubating 48 M adenine with StxA1 for 20 min at 0ЊC prior to addition of the translation mixture. In other competition assays, 120 nM tRNA was added to the translation mixture at time ϭ 0 or time ϭ 5 min before the addition of StxA1. Standard deviations were calculated for each sample in these assays.
Maintenance of Vero cells and cytotoxicity assays. African green monkey kidney (Vero) cells were used for qualitative assessment of the cytotoxic activity of wild-type and mutated STX by a modification of the procedure described by Gentry and Dalrymple (12) . Vero cells were exposed to crude preparations of toxin for 48 h, and cytotoxicity levels were assessed either by crystal violet staining or by measuring the absorbance of viable cells solubilized with 10% SDS. Whole-cell RNA was extracted from monolayers of Vero cells which had been harvested by trypsinization following exposure to native or mutated STX for 16 h. Purified ricin (3.4 mg/ml) (Sigma Chemical Co., St. Louis, Mo.) was used as a control in these experiments. Standard deviations were calculated for each sample in these assays.
Electroporation of Vero cells. Because column-purified StxA1 cannot enter Vero cells via B-subunit-mediated endocytosis, electroporation was developed as an alternate means of enzyme delivery. Vero cells were harvested by trypsinization and diluted to a final concentration of 2 ϫ 10 6 cells per ml. Five hundredmicroliter aliquots were mixed with wild-type or mutated StxA1 at a final concentration of 1.0 ϫ 10 7 molecules per cell, placed in 0.4-cm cuvettes, and electroporated with a Bio-Rad Gene Pulser (voltage ϭ 0.3 kV, capacitance ϭ 960 F). Cells were allowed to rest on ice for 15 min before being added to 500 l of minimal essential medium (MEM) in the wells of a 24-well microtiter plate and incubated for 2 days at 37ЊC in a 5% CO 2 atmosphere. Cells were fixed with formalin and stained with crystal violet. Cytotoxicity was assessed visually based on the relative number of cells remaining fixed in the well.
When RNA was to be isolated from electroporated cells, the voltage was reduced to 0.27 kV. Following incubation on ice for 15 min, 3-to 500-l aliquots of cells were added to 2 ml of MEM in tissue culture dishes (60 by 15 mm) and incubated for 24 h prior to RNA isolation.
Isolation of whole-cell RNA from Vero cells. Total RNA was isolated from Vero cells by a modification of the SDS-acid phenol-chloroform extraction method described by Liu et al. (21) . Cells released into the culture supernatant were combined with those harvested by trypsinization from 25-cm 2 tissue culture flasks. When RNA was isolated from cells following electroporation, cells were collected by scraping the tissue culture dish rather than by treatment with trypsin. Concentrated Vero cells were resuspended in 100 l of MEM and aliquoted into 2-to 1. Following overnight precipitation at Ϫ20ЊC, RNA was collected by microcentrifugation at full speed for 10 min at 4ЊC and resuspended in 10 l of H 2 O. RNA concentration was determined spectrophotometrically, with 1 A 260 unit ϭ 40 g/ml.
Northern blot analysis. Aniline was used to cleave the rRNA backbone at the site depurinated by StxA1 or RTA according to the method of Sallustio and Stanley (26) . Briefly, 6.6 g of RNA was mixed with 13.2 l of freshly prepared 1.0 M aniline buffer (50 l of glacial acetic acid, 700 l of H 2 O, 100 l of aniline, and 250 l of 1.0 M acetic acid), and samples were incubated on ice in the dark for 10 min. The reaction was terminated by the addition of 200 l of H 2 O, and the aniline was removed by evaporation of the sample to dryness in vacuo. Aniline-treated whole-cell RNA or equivalent concentrations of untreated RNA were mixed with 15 l of glyoxal-dimethyl sulfoxide denaturing solution (1.8 ml of 6 M glyoxal, 5.3 ml of dimethyl sulfoxide, 1.0 ml of 100 mM sodium phosphate [pH 7.0], and 1.8 ml of H 2 O) and incubated at 50ЊC for 1 h prior to electrophoresis in 1.4% agarose.
Following electrophoresis, gels were stained briefly with ethidium bromide and the RNA was visualized by the IS-1000 Imaging System (Alpha Innotech Corp., San Leandro, Calif.). Gels were soaked in 0.05 M sodium hydroxide for 20 min, rinsed with H 2 O, and soaked for 45 min in 20ϫ SSC (3 M sodium chloride, 0.3 M sodium citrate [1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate]). RNA was transferred overnight to ZetaProbe GT nylon membranes (Bio-Rad) which were baked for 1.5 h at 80ЊC in vacuo to immobilize the nucleic acids. Membranes were incubated at 65ЊC for 3 h in 10 ml of a hybridization solution consisting of 30% (vol/vol) 20ϫ SSC, 0.2% (wt/vol) SDS, 0.2% (wt/vol) Ficoll type 400, 0.2% (wt/vol) bovine serum albumin fraction V, 0.2% polyvinylpyrrolidone, and 200 g of sheared DNA per ml. RNA probes I and II (Table 2) (23) and spans the site depurinated by RIPs; RNA probe II is complementary to positions 4566 to 4591 of human 28S rRNA and is immediately 3Ј to the depurination site. RNA blots were incubated overnight in hybridization solution containing 10 l of the labeled RNA probe I or II. Blots were washed with 6ϫ SSC at 50ЊC and exposed to X-ray film for 5 to 6 h with a Coronex Lightning Plus intensifying screen (Dupont, Wilmington, Del.). The IS-1000 Imaging System (Alpha Innotech Corp.) was used to quantify the concentration of rRNA in each lane of the Northern blots.
RESULTS

Vero cell cytotoxicity of wild-type and mutated STX. Vero cells were treated with a 10
4 -fold dilution of crude preparations containing native STX and STX with the E167D and W203A/G204A/R205A A subunit substitutions. Figure 1 shows the average results of six separate experiments. STX reduced cell viability to nearly 0, while STX-E167D was approximately fivefold less cytotoxic. STX-W203A/G204A/R205A was approximately eightfold less cytotoxic than native STX. These cytotoxicity assays provided a qualitative assessment of the effects of the amino acid substitutions on activity since the concentrations of native and mutated STX in the crude lysates may vary.
Enzymatic activity of native and mutated StxA1. An in vitro translation assay programmed with luciferase mRNA was used to assess the enzymatic activities of wild-type and mutated StxA1 which was purified by the pET expression system. The concentration of A1 polypeptide which reduced translation (monitored by using luciferase levels) by 50% in comparison to untreated controls was expressed as the 50% ribosome inhibitory concentration (RIC 50 ). Because the pET system was used for protein purification, the STX A1 polypeptide used in this study carried six His residues at the C terminus which may have affected activity.
RIC 50 s (in nanomolars) of protein synthesis inhibitors were as follows: StxA1, 0.009; StxA1-E167D, 18.0; StxA1-W203A/ G204A/R205A, 2.0 ϫ 10 3 ; ricin A, 0.048; puromycin, 160.0. Native StxA1 and the RTA were the most potent inhibitors of protein synthesis, with RIC 50 s of 9 and 48 pM, respectively. StxA1 with the catalytic site mutation E167D was approximately 10 3 -fold less active than the native enzyme with an RIC 50 of 18 nM. The W203A/G204A/R205A substitutions, which involved residues in the putative rRNA-binding domain of StxA1, reduced the RIC 50 of the polypeptide to 2.0 M. Puromycin, which was used as a control because it is a structural analog of aminoacyl-tRNA, had an RIC 50 of 160 nM.
Competition between StxA1 and adenine or tRNA. Since adenine is the product of the StxA1-catalyzed depurination of rRNA (8) , it presumably interacts directly with the active site of the enzyme. Attempts to demonstrate binding of [ 3 H]adenine to the active site of StxA1 by equilibrium dialysis and immunoprecipitation were unsuccessful. However, preincubation of StxA1 with adenine prior to treatment of the rabbit reticulocyte lysate in an in vitro translation assay did abrogate enzymatic activity. Adenine at a final concentration of 48 M, which was the maximum concentration that did not affect pro- Reagents were used at the following concentrations: StxA1, 9 pM; adenine, ATP, AMP, and GTP, 48 M; tRNA, 120 nM. Adenine, ATP, AMP, and GTP were incubated with StxA1 for 20 min on ice prior to their addition to the reticulocyte lysate. tRNA was added to the reticulocyte lysate simultaneously with StxA1 (t ϭ 0) or 5 min after the addition of StxA1 (t ϭ 5). Ribosome activity is expressed relative to that of an untreated control. tein synthesis (Fig. 2 and 3) , restored ribosome activity in a lysate exposed to the RIC 50 of StxA1 to near-untreated levels (Fig. 3) .
The nucleoside monophosphate AMP and triphosphates ATP and GTP were also tested for the capacity to block the enzymatic activity of StxA1 based on their structural relatedness to adenine. Each of these compounds was tested at 48 M since this concentration had no inhibitory effect on the in vitro translation assay. In contrast to adenine, which inhibited StxA1, neither ATP, GTP, nor AMP protected the ribosomes in vitro (Fig. 3) .
The adenine removed from rRNA by RIPs is located in the acceptor site groove of the ribosome. Since this is also the location where tRNA binds during translation, we next examined the ability of an excess concentration of tRNA to compete with StxA1 for binding to the ribosome. As with adenine, it was necessary to first determine the highest concentration of tRNA which would not inhibit the in vitro translation assay. As shown in Fig. 4 , 120 nM rabbit liver tRNA did not significantly inhibit the ability of ribosomes to translate luciferase mRNA. This concentration of tRNA was added to the reticulocyte lysate simultaneously with 9 pM StxA1 (t ϭ 0) or 5 min after exposure to the enzyme (t ϭ 5). Simultaneous addition of 120 nM tRNA protected ribosomes from complete inactivation by StxA1 and maintained ribosome activity at 70% of the untreated control values (Fig. 3) . In contrast, the addition of excess tRNA 5 min after exposure of the ribosomes to StxA1 had no protective effect; the translational capacity of the lysate remained at 50% as expected for the 9 pM RIC 50 of StxA1 (Fig. 3) .
Oxidation of Trp203 and its effect on StxA1 activity. The increased RIC 50 of StxA1-W203A/G204A/R205A (2.0 M) compared to wild-type StxA1 (9 pM) indicated that the fidelity of these residues is required for activity. In an attempt to assess the contribution of the sole tryptophan at position 203 of StxA1, this residue was chemically modified with NBS.
Unmodified StxA1 at a final concentration of 41 nM completely inhibited protein synthesis (Fig. 5) . In contrast, the same concentration of StxA1 which had been modified with NBS reduced translational activity of the rabbit reticulocyte lysate to 28% of that of the untreated control (Fig. 5) . Therefore, the selective oxidation of tryptophan 203 by NBS reduced the activity of StxA1 approximately 4,000-fold: the concentration of NBS-modified enzyme required to reduce ribosome activity was 41 nM in comparison to an RIC 50 of 9 pM for the untreated A1 polypeptide (Fig. 5) .
Northern blot analysis of rRNA isolated from intoxicated Vero cells. In addition to assays which measured the capacity of native and mutated STX to inhibit protein synthesis and affect cell viability, we used Northern blot analysis to directly assess the capacity of the A1 polypeptide to specifically depurinate 28S rRNA in toxin-treated Vero cells. Depurination was visualized as a 400-nucleotide fragment released from the 3Ј end of 28S rRNA from cells which had been exposed to STX or ricin and treated with aniline to cleave the phosphodiester backbone. Because RNA probe II (Table 2 ) was complementary to the region of 28S rRNA immediately 3Ј to the site depurinated by RIPs (A-4324 in mammalian 28S rRNA) (8), it will hybridize with intact 28S rRNA or the 400-nucleotide fragment released from the 3Ј end of 28S rRNA by exposure to StxA1 or RTA and aniline.
Northern blot analysis showed that exposure of Vero cells to ricin converted 100% of the 28S rRNA to the 400-nucleotide fragment upon treatment with aniline (Fig. 6, lane 6) . Interestingly, crude extracts from E. coli HB101(pBR329), which was a negative control for the strain expressing recombinant STX, expressed some depurinating activity in the Northern blot assay (Fig. 6, lane 2) . Lanes 3 and 4 of Fig. 6 show the unmodified 28S rRNA from untreated Vero cells.
Northern analysis of rRNA isolated from Vero cells exposed to crude preparations of STX revealed that 87% of full-length 28S rRNA was converted to the 400-nucleotide fragment (Fig.  7, lane 2) . Substitution of the active site glutamic acid residue at position 167 with an aspartic acid reduced the depurinating capacity to 56% of wild-type levels (Fig. 7, lane 4) . In contrast to the in vitro translation assays which showed that alteration of tryptophan 203 and adjacent residues profoundly reduced activity, STX with the W203A/G204A/R205A substitutions retained 77% of wild-type depurination activity (Fig. 7, lane 6) .
A second oligonucleotide designated RNA probe I (Table 2 ) was used in Northern blot analysis of rRNA isolated from Vero cells exposed to STX-W203A/G204A/R205A. Because RNA Northern analysis with RNA probe I confirmed our previous findings that STX with the W203A/G204A/R205A substitutions in the A subunit retains the capacity to specifically depurinate 28S rRNA (Fig. 8) .
Electroporation of Vero cells. Since purified forms of native and mutated StxA1 lacked B subunits and were unable to enter Vero cells via receptor-mediated endocytosis, we developed electroporation as an alternate means of delivering and assessing the depurination capacity of these enzymes.
Northern blot analysis was performed on rRNA isolated from Vero cells electroporated with native StxA1 and StxA1 with the E167D and W203A/G204A/R205A substitutions. Native StxA1 delivered by electroporation depurinated the 28S rRNA and permitted release of the 400-nucleotide fragment by aniline (Fig. 9, lane 2) . A weak band was also detected in lane 3 of Fig. 9 , suggesting that StxA1 with the E167D substitution retains some capacity to depurinate 28S rRNA.
DISCUSSION
The effects of various amino acid substitutions in the putative active sites of StxA1 have been previously reported (2, 16, 18, 33) . Results of the current study provided the specific activities of purified StxA1 and two mutated forms of the polypeptide. The substitution E167D caused a 2,000-fold increase in the RIC 50 of StxA1, corroborating earlier mutagenesis studies (16, 18, 33) which showed that this conservative amino acid substitution resulted in a 100-to 1,000-fold reduction in activity by the cell-free translation assay. This glutamic acid has been established as an active site residue among other members of the RIP family of enzymes (24, 29) . StxA1 with the W203A-R205A substitution had an RIC 50 of 2 M, confirming a previous mutagenesis study by Yamasaki and coworkers (33) which showed that tryptophan 203 and arginine 205 are important for enzymatic activity.
The target site adenine for RIPs is on a stem-loop structure which protrudes into the acceptor site groove of the large ribosomal subunit (3, 4) . This is the rRNA domain involved in EF-1-dependent binding of aminoacyl tRNAs to the ribosome and in EF-2-catalyzed GTP hydrolysis and translocation of peptidyl tRNA to the P site. Normally, binding of EF-2 protects 28S rRNA against depurination by ricin (9). However, when Trp-221 of EF-2 was chemically modified with NBS ribosomes, it became sensitive to ricin, indicating that Trp-221 must be part of an amino acid sequence which is involved in the interaction of EF-2 with nucleotides in the ricin-sensitive loop (14) . Chemical modification of tryptophan 203 in the STX A1 polypeptide with NBS reduced enzymatic activity 4,000-fold, establishing the role of this residue in activity. Because tryptophan 203 lies in the active site cleft of StxA1 and modification of this residue affects activity, we propose that it interacts with the phosphodiester backbone to properly orient the 28S rRNA prior to depurination.
RIP-mediated cleavage of an N-glycosidic bond in 28S rRNA renders the phosphodiester bonds on either side of the ribose susceptible to a ␤-elimination reaction which can be catalyzed at an acidic pH by primary amines such as aniline (6) . Chain scission releases a small fragment from the 3Ј end of rRNA which we quantified by Northern analysis with a specific oligonucleotide probe. Therefore, the effects of amino acid substitutions in the A1 polypeptide were assessed as the conversion of 28S rRNA to the 400-nucleotide fragment. Blots of rRNA isolated from cells treated with a crude preparation of wild-type STX revealed that 87% of the 28S rRNA was converted to the 400-nucleotide fragment. The E167D substitution in STX reduced this conversion to 56% of the total 28S rRNA in Northern blot assays. Results of the in vitro translation assay using StxA1-E167D corroborated this finding: the enzymatic activity was reduced 1,000-fold in comparison to native STX but was not completely abolished. We hypothesize that the shortened carboxylate side chain of aspartic acid in comparison to glutamic acid was suboptimal for stabilization of the ribose oxycarbonium transition state intermediate which precedes the depurination reaction.
The effects of the W203A/G204A/R205A substitutions in the A1 polypeptide were more puzzling. While the specific activity of this mutated form of StxA1 was reduced 10 5 -fold in comparison to the native A1 polypeptide, Northern blot analysis revealed that 77% of the 28S rRNA isolated from Vero cells intoxicated with STX-W203A/G204A/R205A was converted to the cleaved form. STX carrying these substitutions retains the catalytic site glutamic acid 167 which is required for protonation of the target adenine and stabilization of the oxycarbonium intermediate but is disrupted in the downstream region believed to be involved with stabilizing the interaction of the enzyme with the ribose-phosphate backbone. Therefore, these mutations may have reduced the capacity of StxA1 binding in the relatively short time frame of the translation assay (approximately 2 h) while the longer incubation period required to intoxicate the Vero cells for Northern analysis (16 h) may have permitted additional interactions between the rRNA backbone and amino acids outside the active site cleft of StxA1. These interactions may have been adequate for lowlevel binding and depurination at a reduced efficiency compared to the wild-type enzyme. The extended incubation time for Vero cell intoxication was required for B subunit-mediated entry and translocation of STX to its target site.
It was necessary to develop electroporation as a means for delivering the purified A1 polypeptide into Vero cells. Due to the inefficiency of electroporation as a delivery method, as well as the high rate of cell death induced by this technique, it was necessary to use a ratio of 1.0 ϫ 10 7 molecules of StxA1 per Vero cell in these assays. Northern analysis of rRNA isolated from the electroporated cells was consistent with the results with STX. In future studies, the delivery and translocation route of electroporated A1 polypeptide will be compared to the native route mediated by the B subunits.
Competition studies were conducted with tRNA because the adenine removed from 28S rRNA by RIPs is located in the acceptor site groove of ribosomes and the crystal structures of StxA1 and RTA resemble a tRNA molecule. Our results demonstrated that the simultaneous addition of excess tRNA protected ribosomes from inactivation by StxA1 while the addition of tRNA 5 min after StxA1 was not effective. This indicates that StxA1 and tRNA compete for binding to the acceptor site groove of ribosomes.
Since adenine is the product of the N-glycosidase activity of RIPs, we reasoned that it would bind directly to the active site of StxA1 (32) . However, attempts to demonstrate direct binding of adenine to the A1 polypeptide by equilibrium dialysis were unsuccessful. This same result was previously reported by Zamboni et al. (34) with RTA. In comparison to the tetra-loop target site in 28S rRNA, free adenine may be too small to bind the RIP active site cleft. Although we could not demonstrate direct binding, a molar excess of adenine was used in the competition experiments to overcome the transient binding of the free base to the active site cleft of StxA1 and effectively inhibit enzymatic activity. These competition studies indicate that it may be possible to develop chemical intervention strategies which could be used therapeutically to protect mammalian cells from intoxication by members of the STX family.
